| Dr Kent Steven Hesse, MD | |
|
138 Russell St, Hadley, MA 01035-9533 | |
| (413) 587-4680 | |
| (413) 587-4682 |
| Full Name | Dr Kent Steven Hesse |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 42 Years |
| Location | 138 Russell St, Hadley, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457470593 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cooley Dickinson Hospital Inc,the | Northampton, MA | Hospital |
| Baystate Medical Center | Springfield, MA | Hospital |
| Holyoke Medical Center | Holyoke, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Servicenet Inc | 6901797950 | 60 |
News Archive
A new study by researchers at Wake Forest University Baptist Medical Center and colleagues shows that a drug originally used to treat breast cancer may help combat the severe weight loss that can plague patients undergoing radiation treatment for lung and head and neck cancer.
DBV Technologies, creator of Viaskin, a new standard in the treatment of allergies, announced today that it entered into a strategic manufacturing agreement with Sanofi to produce Viaskin's Active Pharmaceutical Ingredients (API), such as the peanut protein extract.
Scientists estimate that nearly 60% of all cancer patients do not respond effectively to chemotherapy treatments. Even worse - many of those same patients experience toxic and sometimes deadly side effects.
For patients with chronic kidney disease (CKD), the risk of elevated levels of parathyroid hormone (PTH), or hyperparathyroidism a significant complication that increases the risk of cardiovascular problems and death increases along with body weight, reports a study in the September Clinical Journal of the American Society of Nephrology.
"The World Health Organization on Wednesday urged health workers around the world to report any patient with acute respiratory infection who may have traveled to Saudi Arabia or Qatar and been exposed to a new SARS-like virus confirmed in two people so far," Reuters reports.
› Verified 1 days ago
| Entity Name | Servicenet Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659314425 PECOS PAC ID: 6901797950 Enrollment ID: O20040322000368 |
News Archive
A new study by researchers at Wake Forest University Baptist Medical Center and colleagues shows that a drug originally used to treat breast cancer may help combat the severe weight loss that can plague patients undergoing radiation treatment for lung and head and neck cancer.
DBV Technologies, creator of Viaskin, a new standard in the treatment of allergies, announced today that it entered into a strategic manufacturing agreement with Sanofi to produce Viaskin's Active Pharmaceutical Ingredients (API), such as the peanut protein extract.
Scientists estimate that nearly 60% of all cancer patients do not respond effectively to chemotherapy treatments. Even worse - many of those same patients experience toxic and sometimes deadly side effects.
For patients with chronic kidney disease (CKD), the risk of elevated levels of parathyroid hormone (PTH), or hyperparathyroidism a significant complication that increases the risk of cardiovascular problems and death increases along with body weight, reports a study in the September Clinical Journal of the American Society of Nephrology.
"The World Health Organization on Wednesday urged health workers around the world to report any patient with acute respiratory infection who may have traveled to Saudi Arabia or Qatar and been exposed to a new SARS-like virus confirmed in two people so far," Reuters reports.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kent Steven Hesse, MD 138 Russell St, Hadley, MA 01035-9533 Ph: (413) 587-4680 | Dr Kent Steven Hesse, MD 138 Russell St, Hadley, MA 01035-9533 Ph: (413) 587-4680 |
News Archive
A new study by researchers at Wake Forest University Baptist Medical Center and colleagues shows that a drug originally used to treat breast cancer may help combat the severe weight loss that can plague patients undergoing radiation treatment for lung and head and neck cancer.
DBV Technologies, creator of Viaskin, a new standard in the treatment of allergies, announced today that it entered into a strategic manufacturing agreement with Sanofi to produce Viaskin's Active Pharmaceutical Ingredients (API), such as the peanut protein extract.
Scientists estimate that nearly 60% of all cancer patients do not respond effectively to chemotherapy treatments. Even worse - many of those same patients experience toxic and sometimes deadly side effects.
For patients with chronic kidney disease (CKD), the risk of elevated levels of parathyroid hormone (PTH), or hyperparathyroidism a significant complication that increases the risk of cardiovascular problems and death increases along with body weight, reports a study in the September Clinical Journal of the American Society of Nephrology.
"The World Health Organization on Wednesday urged health workers around the world to report any patient with acute respiratory infection who may have traveled to Saudi Arabia or Qatar and been exposed to a new SARS-like virus confirmed in two people so far," Reuters reports.
› Verified 1 days ago